National Institute Of Arthritis And Musculoskeletal And Skin Diseases Notice of Meeting, 52142 [2020-18441]

Download as PDF 52142 Federal Register / Vol. 85, No. 164 / Monday, August 24, 2020 / Notices Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute Of Arthritis And Musculoskeletal And Skin Diseases Notice of Meeting jbell on DSKJLSW7X2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council. The meeting will be open to the public online as indicated below, with attendance limited to online participation only. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Arthritis and Musculoskeletal and Skin Diseases Advisory Council. Date: September 1, 2020. Open: 10:00 a.m. to 12:45 p.m. Agenda: To discuss program policies and issues. Place: National Institutes of Health, Bethesda, MD, (Virtual Meeting). Virtual Access: The meeting will be videocast and can be accessed from the NIH Videocast https://videocast.nih.gov. Please note, the link to the videocast meeting will be posted within a week of the meeting date. Any member of the public may submit written comments no later than 15 days after the meeting. Closed: 2:00 p.m.–3:30 p.m. Agenda: To Review and Evaluate Grant Applications. Contact Person: Melinda Nelson, Acting Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grants Management Branch, 45 Center Drive, Natcher Building, Room 5A49, Bethesda, MD 20892, (301) 594–3535, mn23z@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Any interested person may file written comments with the committee by forwarding the statement to the VerDate Sep<11>2014 16:31 Aug 21, 2020 Jkt 250001 Dated: August 18, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–18441 Filed 8–21–20; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel Small Business: Low Vision, Ocular Biomedical and Bioengineering Technology Development. Date: September 14, 2020. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Susan Gillmor, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, (240) 762–3076, susan.gillmor@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel NIH Research Enhancement Award (R15) in Oncological Sciences. Date: September 16, 2020. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Svetlana Kotliarova, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, Bethesda, MD 20892, (301) 594–7945, kotliars@mail.nih.gov. Fmt 4703 [FR Doc. 2020–18439 Filed 8–21–20; 8:45 am] Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review Notice of Closed Meetings Frm 00058 Dated: August 18, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES PO 00000 (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) National Heart, Lung, and Blood Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Heart, Lung, and Blood Advisory Council. The meeting will be open to the public as indicated below and held as a virtual meeting. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Heart, Lung, and Blood Advisory Council. Date: September 15, 2020. Open: 8:00 a.m. to 11:00 a.m. Agenda: To discuss program policies and issues. Place: National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Room 206–Q, Bethesda, MD 20892, (Virtual Meeting). Open: 1:30 p.m. to 4:00 p.m. Agenda: To discuss program policies and issues. Place: National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Room 206–Q, Bethesda, MD 20892, (Virtual Meeting). Virtual Access: The meeting will be videocast and can be accessed from the NIH Videocast. Please note, the link to the videocast meeting will be posted within a week of the meeting date on the NHLBI Council website: https://www.nhlbi.nih.gov/ about/advisory-and-peer-review-committees/ advisory-council. Contact Person: Laura K. Moen, Ph.D., Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD 20892, 301–435–0260, moenl@ mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when E:\FR\FM\24AUN1.SGM 24AUN1

Agencies

[Federal Register Volume 85, Number 164 (Monday, August 24, 2020)]
[Notices]
[Page 52142]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-18441]



[[Page 52142]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute Of Arthritis And Musculoskeletal And Skin 
Diseases Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Arthritis 
and Musculoskeletal and Skin Diseases Advisory Council.
    The meeting will be open to the public online as indicated below, 
with attendance limited to online participation only. Individuals who 
plan to attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Arthritis and Musculoskeletal and 
Skin Diseases Advisory Council.
    Date: September 1, 2020.
    Open: 10:00 a.m. to 12:45 p.m.
    Agenda: To discuss program policies and issues.
    Place: National Institutes of Health, Bethesda, MD, (Virtual 
Meeting).
    Virtual Access: The meeting will be videocast and can be 
accessed from the NIH Videocast https://videocast.nih.gov. Please 
note, the link to the videocast meeting will be posted within a week 
of the meeting date. Any member of the public may submit written 
comments no later than 15 days after the meeting.
    Closed: 2:00 p.m.-3:30 p.m.
    Agenda: To Review and Evaluate Grant Applications.
    Contact Person: Melinda Nelson, Acting Director, National 
Institute of Arthritis and Musculoskeletal and Skin Diseases, Grants 
Management Branch, 45 Center Drive, Natcher Building, Room 5A49, 
Bethesda, MD 20892, (301) 594-3535, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.

    Dated: August 18, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-18441 Filed 8-21-20; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.